The “Healthcare” practice at MarketsandMarkets is pleased to announce its “Analyst Briefing Presentation” on the “Protein Engineering Market [Products (Monoclonal Antibody, Insulin Analog, Modified EPO), Technology (Sequential Modification, Glycosylation, PEGylation), and Applications (Therapeutics, Diagnostics, Research)] – Global Forecast to 2017”.
Proteins are widely being used as therapeutics because of their high specificity and less immunogenicity properties. With development in the field of molecular and structural biology, more proteins are being engineered to develop effective therapeutic drugs. The growth of the market is majorly focused on monoclonal antibodies, which contribute more than 50% in revenue. In therapeutics, the use of monoclonal antibodies for conditions like oncology, and autoimmune and inflammatory diseases is set to increase in future; thisis likely to play a key role in the growth of the overall market. Development of techniques like sequence modification, glycosylation, PEGylation, display technologies, and production systems like transgenic plants, and animals and mammalian cell line has increased the prospects of developing new drugs.
The market is forecast based on products’ growth trend and analysis of their applications. The global market for protein engineering, in terms of revenue, was estimated to be worth $100 billion in 2012 and is expected to reach $168 billion by 2017, growing at a CAGR of 10.9% from 2012 to 2017.
A bottom-up approach was used to estimate market size. The key players in the market were identified through secondary research and revenue of their products was determined through annual reports and secondary research. The size of the protein engineering market was derived from the revenue of engineered protein products and monoclonal antibodies.
The briefing will cover an overview of drivers, restraints and opportunities present in the market. It will also includegrowing technologies and market trends of the global protein engineering market.
- RESEARCH METHODOLOGY
- Market size
|Global Protein Engineering Market|
|A bottom-up was used approach to calculate the global protein engineering market for therapeutic and diagnostics applications
A geographic split-up was given post calculating the sale of engineered protein products in the market
Key data points were collected from public and paid secondary databases and successively validated from primary sources
- Market share
|Global protein engineering market for therapeutics, diagnostics and research applications
Global protein engineering market by products for therapeutic applications
Global protein engineering market by technology
|Market share for these segments has been discussed on the basis of interviews with Vice Presidents, Chief Executive Officers, Marketing Managers of major companies, and small and medium enterprises.|
- Key Data Points from secondary sources
|Market Revenue||Company Financials, Magazines, Journals, Press Releases, Paid Databases, and MnM Data Repository|
|Market Revenue of Companies||Annual Reports, Company Websites, Public Databases, and MnM DataRepository|
|Qualitative Information (Market Dynamics, Market Trends)||Company Websites, Annual Reports, Press Releases, Databases, and MnM Data Repository|
|Protein Engineering Market for Diagnostic Applications||The global protein engineering market for diagnostic applications was estimated by assuming that monoclonal antibodies are used 90% in diagnostic applications|
|Market for Insulin and Cancer therapeutics||Future potential for insulin analogs and cancer therapeutics was derived based on number of incidence per 100,000.|
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
North – Dominion Plaza,
17304 Preston Road,
Suite 800, Dallas, TX 75252